TOIIW
The Oncology Institute, Inc.
Price Chart
Latest Quote
$0.06
+0.02 (+33.71%)
Current Price
| Previous Close | $0.04 |
| Open | $0.18 |
| Day High | $0.06 |
| Day Low | $0.06 |
| Volume | 100 |
Stock Information
| Total Debt | $104.91M |
| Cash Equivalents | $30.28M |
| Revenue | $545.76M |
| Net Income | $-36.32M |
| EPS (TTM) | $-602.09 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Sales | $545.76M |
| Income | $-36.32M |
| Book/sh | $-0.16 |
| Employees | 641 |
Financial Ratios
| Quick Ratio | 1.13 |
| Current Ratio | 1.47 |
Returns & Margins
| ROA | -12.30% |
| Gross Margin | 15.12% |
| Operating Margin | -4.42% |
| Profit Margin | -7.97% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | -0.37 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.05 |
| SMA50 | $0.05 |
| RSI | nan |
| Shares Float | 87.35M |
| Volatility | 0.41 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | +0.00% |
| YTD | +17.02% |
| 10 Years | +17.02% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-12 | $0.05 | 0 |
| 2026-06-11 | $0.05 | 0 |
| 2026-06-10 | $0.05 | 0 |
| 2026-06-09 | $0.05 | 0 |
| 2026-06-08 | $0.05 | 0 |
| 2026-06-05 | $0.05 | 0 |
| 2026-06-04 | $0.05 | 0 |
| 2026-06-03 | $0.05 | 0 |
| 2026-06-02 | $0.05 | 0 |
| 2026-06-01 | $0.05 | 0 |
| 2026-05-29 | $0.05 | 0 |
| 2026-05-28 | $0.05 | 0 |
| 2026-05-27 | $0.05 | 0 |
| 2026-05-26 | $0.05 | 0 |
| 2026-05-22 | $0.05 | 0 |
| 2026-05-21 | $0.05 | 0 |
| 2026-05-20 | $0.05 | 0 |
| 2026-05-19 | $0.05 | 0 |
| 2026-05-18 | $0.05 | 0 |
About The Oncology Institute, Inc.
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
đ° Latest News
How Much Upside is Left in The Oncology Institute (TOI)? Wall Street Analysts Think 38.07%
Zacks âĸ 2026-06-09T13:55:02Z
The Oncology Institute, Inc. (NASDAQ:TOI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.00
Simply Wall St. âĸ 2026-05-11T16:06:01Z
Oncology Institute Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-09T05:06:14Z
The Oncology Institute, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-08T12:30:00Z
The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-07T23:05:13Z
Hereâs What Powered The Oncology Instituteâs (TOI) Gains
Insider Monkey âĸ 2026-04-20T13:11:45Z
TSX Stocks Including Montage Gold That May Be Trading Below Intrinsic Value Estimates
Simply Wall St. âĸ 2026-04-03T12:37:58Z
One Oncology Institute Insider Raised Their Stake In The Previous Year
Simply Wall St. âĸ 2026-03-31T17:33:02Z
Oncology Institute (TOI) Earnings Transcript
Motley Fool âĸ 2026-03-17T19:58:21Z
The Oncology Institute, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-13T12:30:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $426,294,000 | $339,415,000 | $264,666,000 | $200,390,000 |
| Cost Of Revenue | $426,294,000 | $339,415,000 | $264,666,000 | $200,390,000 |
| Total Revenue | $502,729,000 | $393,412,000 | $324,239,000 | $252,483,000 |
| Operating Revenue | $502,729,000 | $393,412,000 | $324,239,000 | $252,483,000 |
| Expenses | ||||
| Interest Expense | $11,276,000 | $7,496,000 | $6,777,000 | $4,082,000 |
| Total Expenses | $538,812,000 | $453,530,000 | $384,390,000 | $324,490,000 |
| Other Income Expense | $-13,378,000 | $2,951,000 | $-16,176,000 | $75,998,000 |
| Other Non Operating Income Expenses | $-925,000 | $-365,000 | $-704,000 | $501,000 |
| Net Non Operating Interest Income Expense | $-11,276,000 | $-7,496,000 | $-6,777,000 | $-4,082,000 |
| Interest Expense Non Operating | $11,276,000 | $7,496,000 | $6,777,000 | $4,082,000 |
| Operating Expense | $112,518,000 | $114,115,000 | $119,724,000 | $124,100,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-60,606,000 | $-64,663,000 | $-83,068,000 | $152,000 |
| Net Interest Income | $-11,276,000 | $-7,496,000 | $-6,777,000 | $-4,082,000 |
| Normalized Income | $-48,179,151 | $-67,979,000 | $-67,602,702 | $-59,490,630 |
| Net Income From Continuing And Discontinued Operation | $-60,606,000 | $-64,663,000 | $-83,068,000 | $152,000 |
| Total Operating Income As Reported | $-36,083,000 | $-60,118,000 | $-77,018,000 | $-81,951,000 |
| Net Income Common Stockholders | $-50,305,000 | $-53,005,000 | $-67,877,000 | $68,000 |
| Net Income | $-60,606,000 | $-64,663,000 | $-83,068,000 | $152,000 |
| Net Income Including Noncontrolling Interests | $-60,606,000 | $-64,663,000 | $-83,068,000 | $152,000 |
| Net Income Continuous Operations | $-60,606,000 | $-64,663,000 | $-83,068,000 | $152,000 |
| Pretax Income | $-60,737,000 | $-64,663,000 | $-83,104,000 | $-91,000 |
| Operating Income | $-36,083,000 | $-60,118,000 | $-60,151,000 | $-72,007,000 |
| Depreciation Amortization Depletion Income Statement | $6,944,000 | $6,287,000 | $5,873,000 | $4,411,000 |
| Depreciation And Amortization In Income Statement | $6,944,000 | $6,287,000 | $5,873,000 | $4,411,000 |
| Gross Profit | $76,435,000 | $53,997,000 | $59,573,000 | $52,093,000 |
| Special Income Charges | - | $0 | $-16,064,000 | $49,454,000 |
| Average Dilution Earnings | - | - | $0 | $-17,048,000 |
| Other | ||||
| Tax Effect Of Unusual Items | $-26,151 | $0 | $-6,702 | $15,854,370 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-30,064,000 | $-54,196,000 | $-54,982,000 | $-67,095,000 |
| Total Unusual Items | $-12,453,000 | $3,316,000 | $-15,472,000 | $75,497,000 |
| Total Unusual Items Excluding Goodwill | $-12,453,000 | $3,316,000 | $-15,472,000 | $75,497,000 |
| Reconciled Depreciation | $6,944,000 | $6,287,000 | $5,873,000 | $4,411,000 |
| EBITDA (Bullshit earnings) | $-42,517,000 | $-50,880,000 | $-70,454,000 | $8,402,000 |
| EBIT | $-49,461,000 | $-57,167,000 | $-76,327,000 | $3,991,000 |
| Diluted NI Availto Com Stockholders | $-50,305,000 | $-53,005,000 | $-67,877,000 | $-16,980,000 |
| Otherunder Preferred Stock Dividend | $-10,301,000 | $-11,658,000 | $-15,191,000 | $84,000 |
| Tax Provision | $-131,000 | $0 | $-36,000 | $-243,000 |
| Gain On Sale Of Security | $-12,453,000 | $3,316,000 | $592,000 | $26,043,000 |
| Selling General And Administration | $105,574,000 | $107,828,000 | $113,851,000 | $119,689,000 |
| Impairment Of Capital Assets | - | $0 | $16,867,000 | $9,944,000 |
| Restructuring And Mergern Acquisition | - | $0 | $-803,000 | $-59,215,000 |
| Other Special Charges | - | - | - | $-183,000 |
Fetched: 2026-06-13
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-33,965,000 | $-18,451,000 | $31,891,000 | $83,800,000 |
| Total Assets | $164,656,000 | $172,717,000 | $209,240,000 | $261,665,000 |
| Total Non Current Assets | $51,909,000 | $60,299,000 | $65,747,000 | $131,247,000 |
| Other Non Current Assets | $606,000 | $589,000 | $561,000 | $477,000 |
| Goodwill And Other Intangible Assets | $18,245,000 | $22,040,000 | $25,134,000 | $39,375,000 |
| Other Intangible Assets | $11,015,000 | $14,810,000 | $17,904,000 | $17,957,000 |
| Current Assets | $112,747,000 | $112,418,000 | $143,493,000 | $130,418,000 |
| Other Current Assets | $2,987,000 | $4,029,000 | $4,049,000 | - |
| Inventory | $16,875,000 | $10,039,000 | $13,678,000 | $9,261,000 |
| Receivables | $59,320,000 | $48,681,000 | $42,911,000 | $40,433,000 |
| Other Receivables | $322,000 | $346,000 | $551,000 | $343,000 |
| Accounts Receivable | $58,998,000 | $48,335,000 | $42,360,000 | $39,816,000 |
| Cash Cash Equivalents And Short Term Investments | $33,565,000 | $49,669,000 | $82,855,000 | $73,806,000 |
| Cash And Cash Equivalents | $33,565,000 | $49,669,000 | $33,488,000 | $14,010,000 |
| Investmentin Financial Assets | - | - | $0 | $58,354,000 |
| Prepaid Assets | - | - | $4,049,000 | $6,918,000 |
| Accrued Interest Receivable | - | - | $242,000 | $274,000 |
| Restricted Cash | - | - | - | $0 |
| Cash Financial | - | - | - | $14,010,000 |
| Debt | ||||
| Net Debt | $43,835,000 | $43,462,000 | $53,338,000 | $66,611,000 |
| Total Debt | $103,687,000 | $123,152,000 | $119,675,000 | $108,179,000 |
| Long Term Debt And Capital Lease Obligation | $96,531,000 | $116,354,000 | $113,312,000 | $102,681,000 |
| Long Term Debt | $77,400,000 | $93,131,000 | $86,826,000 | $80,621,000 |
| Current Debt And Capital Lease Obligation | $7,156,000 | $6,798,000 | $6,363,000 | $5,498,000 |
| Current Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $180,376,000 | $169,128,000 | $152,215,000 | $138,490,000 |
| Total Non Current Liabilities Net Minority Interest | $109,414,000 | $116,913,000 | $117,427,000 | $108,770,000 |
| Other Non Current Liabilities | $28,000 | $125,000 | $365,000 | $868,000 |
| Derivative Product Liabilities | $12,855,000 | $402,000 | $3,718,000 | $5,113,000 |
| Non Current Deferred Liabilities | $0 | $32,000 | $32,000 | $108,000 |
| Non Current Deferred Taxes Liabilities | $0 | $32,000 | $32,000 | $108,000 |
| Current Liabilities | $70,962,000 | $52,215,000 | $34,788,000 | $29,720,000 |
| Other Current Liabilities | $4,305,000 | $5,310,000 | $3,601,000 | $3,234,000 |
| Current Deferred Liabilities | $4,037,000 | $5,729,000 | $3,296,000 | $1,941,000 |
| Payables And Accrued Expenses | $48,371,000 | $27,403,000 | $19,611,000 | $13,737,000 |
| Interest Payable | $878,000 | $1,136,000 | $1,124,000 | $1,100,000 |
| Payables | $43,167,000 | $24,324,000 | $14,429,000 | $9,627,000 |
| Accounts Payable | $43,167,000 | $24,324,000 | $14,429,000 | $9,372,000 |
| Total Tax Payable | - | - | $0 | $255,000 |
| Income Tax Payable | - | - | $0 | $255,000 |
| Equity | ||||
| Common Stock Equity | $-15,720,000 | $3,589,000 | $57,025,000 | $123,175,000 |
| Total Equity Gross Minority Interest | $-15,720,000 | $3,589,000 | $57,025,000 | $123,175,000 |
| Stockholders Equity | $-15,720,000 | $3,589,000 | $57,025,000 | $123,175,000 |
| Retained Earnings | $-271,419,000 | $-210,813,000 | $-146,150,000 | $-63,082,000 |
| Other | ||||
| Treasury Shares Number | $1,733,774 | $1,733,774 | $1,733,774 | - |
| Ordinary Shares Number | $98,863,144 | $75,737,112 | $74,145,251 | $73,265,621 |
| Share Issued | $100,596,918 | $77,470,886 | $75,879,025 | $73,265,621 |
| Tangible Book Value | $-33,965,000 | $-18,451,000 | $31,891,000 | $83,800,000 |
| Invested Capital | $61,680,000 | $96,720,000 | $143,851,000 | $203,796,000 |
| Working Capital | $41,785,000 | $60,203,000 | $108,705,000 | $100,698,000 |
| Capital Lease Obligations | $26,287,000 | $30,021,000 | $32,849,000 | $27,558,000 |
| Total Capitalization | $61,680,000 | $96,720,000 | $143,851,000 | $203,796,000 |
| Treasury Stock | $1,019,000 | $1,019,000 | $1,019,000 | $0 |
| Additional Paid In Capital | $256,708,000 | $215,413,000 | $204,186,000 | $186,250,000 |
| Capital Stock | $10,000 | $8,000 | $8,000 | $7,000 |
| Common Stock | $10,000 | $8,000 | $8,000 | $7,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $19,131,000 | $23,223,000 | $26,486,000 | $22,060,000 |
| Current Deferred Revenue | $2,282,000 | $2,351,000 | $1,090,000 | $1,139,000 |
| Current Capital Lease Obligation | $7,156,000 | $6,798,000 | $6,363,000 | $5,498,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $7,093,000 | $6,975,000 | $5,518,000 | $5,310,000 |
| Current Accrued Expenses | $5,204,000 | $3,079,000 | $5,182,000 | $4,110,000 |
| Goodwill | $7,230,000 | $7,230,000 | $7,230,000 | $21,418,000 |
| Net PPE | $33,058,000 | $37,670,000 | $40,052,000 | $33,041,000 |
| Accumulated Depreciation | $-10,926,000 | $-6,972,000 | $-6,180,000 | $-3,506,000 |
| Gross PPE | $43,984,000 | $44,642,000 | $46,232,000 | $36,547,000 |
| Leases | $12,849,000 | $12,502,000 | $9,214,000 | $6,655,000 |
| Construction In Progress | $1,137,000 | $106,000 | $1,801,000 | $1,144,000 |
| Other Properties | $24,080,000 | $27,434,000 | $31,458,000 | $26,003,000 |
| Machinery Furniture Equipment | $5,918,000 | $4,600,000 | $3,759,000 | $2,745,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $16,875,000 | $10,039,000 | $13,678,000 | $9,261,000 |
| Other Short Term Investments | - | $0 | $49,367,000 | $59,796,000 |
| Investments And Advances | - | - | $0 | $58,354,000 |
| Available For Sale Securities | - | - | - | $58,354,000 |
| Line Of Credit | - | - | - | - |
Fetched: 2026-06-13
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-27,787,000 | $-30,327,000 | $-40,882,000 | $-67,285,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-24,587,000 | $-26,538,000 | $-36,315,000 | $-61,756,000 |
| Cash Flow From Continuing Operating Activities | $-24,587,000 | $-26,538,000 | $-36,315,000 | $-61,756,000 |
| Operating Gains Losses | $14,851,000 | $-3,045,000 | $-622,000 | $-26,205,000 |
| Investing Activities | ||||
| Capital Expenditure | $-3,200,000 | $-3,789,000 | $-4,567,000 | $-5,529,000 |
| Investing Cash Flow | $-3,074,000 | $46,211,000 | $62,640,000 | $-131,614,000 |
| Cash Flow From Continuing Investing Activities | $-3,074,000 | $46,211,000 | $62,640,000 | $-131,614,000 |
| Net Other Investing Changes | $126,000 | - | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $29,200,000 | $0 | - | $0 |
| Financing Cash Flow | $11,557,000 | $-3,492,000 | $-6,847,000 | $92,206,000 |
| Cash Flow From Continuing Financing Activities | $11,557,000 | $-3,492,000 | $-6,847,000 | $92,206,000 |
| Net Other Financing Charges | $-1,041,000 | $-3,528,000 | $-5,853,000 | $-9,594,000 |
| Net Common Stock Issuance | $29,200,000 | $0 | $-1,019,000 | $-9,000,000 |
| Common Stock Issuance | $29,200,000 | $0 | - | - |
| Repurchase Of Capital Stock | - | $0 | $-1,019,000 | $-9,000,000 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-20,037,000 | $-39,000 | $-101,000 | $-58,000 |
| Interest Paid Supplemental Data | $3,914,000 | $4,498,000 | $4,506,000 | $224,000 |
| End Cash Position | $33,565,000 | $49,669,000 | $33,488,000 | $14,010,000 |
| Beginning Cash Position | $49,669,000 | $33,488,000 | $14,010,000 | $115,174,000 |
| Changes In Cash | $-16,104,000 | $16,181,000 | $19,478,000 | $-101,164,000 |
| Proceeds From Stock Option Exercised | $3,435,000 | $75,000 | $126,000 | $858,000 |
| Net Issuance Payments Of Debt | $-20,037,000 | $-39,000 | $-101,000 | $109,942,000 |
| Net Long Term Debt Issuance | $-20,037,000 | $-39,000 | $-101,000 | $109,942,000 |
| Long Term Debt Payments | $-20,037,000 | $-39,000 | $-101,000 | $-58,000 |
| Net Investment Purchase And Sale | $0 | $50,000,000 | $71,663,000 | $-117,508,000 |
| Sale Of Investment | $0 | $50,000,000 | $81,258,000 | $0 |
| Net PPE Purchase And Sale | $-3,200,000 | $-3,789,000 | $-4,567,000 | $-5,529,000 |
| Purchase Of PPE | $-3,200,000 | $-3,789,000 | $-4,567,000 | $-5,529,000 |
| Change In Working Capital | $1,325,000 | $18,059,000 | $2,359,000 | $-20,541,000 |
| Change In Other Working Capital | $-452,000 | $559,000 | - | - |
| Change In Other Current Liabilities | $-11,000 | $-203,000 | $-5,767,000 | $-4,958,000 |
| Change In Other Current Assets | $-17,000 | $-28,000 | $5,722,000 | $5,247,000 |
| Change In Payables And Accrued Expense | $19,190,000 | $18,686,000 | $8,159,000 | $-3,715,000 |
| Change In Accrued Expense | $-448,000 | $9,471,000 | $3,357,000 | $2,349,000 |
| Change In Payable | $19,638,000 | $9,215,000 | $4,802,000 | $-6,064,000 |
| Change In Account Payable | $19,638,000 | $9,215,000 | $5,057,000 | $-6,187,000 |
| Change In Prepaid Assets | $2,033,000 | $1,176,000 | $3,128,000 | $4,282,000 |
| Change In Inventory | $-6,836,000 | $3,639,000 | $-4,385,000 | $-1,732,000 |
| Change In Receivables | $-12,582,000 | $-5,770,000 | $-4,498,000 | $-19,665,000 |
| Changes In Account Receivables | $-12,308,000 | $-5,975,000 | $-4,564,000 | $-20,285,000 |
| Other Non Cash Items | $8,380,000 | $6,305,000 | $5,402,000 | $-56,771,000 |
| Stock Based Compensation | $4,551,000 | $11,152,000 | $17,810,000 | $27,683,000 |
| Unrealized Gain Loss On Investment Securities | $0 | $-133,000 | $-249,000 | $378,000 |
| Amortization Of Securities | $0 | $-500,000 | $-2,631,000 | $-1,020,000 |
| Deferred Tax | $-32,000 | $0 | $-76,000 | $-263,000 |
| Deferred Income Tax | $-32,000 | $0 | $-76,000 | $-263,000 |
| Depreciation Amortization Depletion | $6,944,000 | $6,287,000 | $5,873,000 | $4,411,000 |
| Depreciation And Amortization | $6,944,000 | $6,287,000 | $5,873,000 | $4,411,000 |
| Gain Loss On Investment Securities | $14,851,000 | $-3,316,000 | $-592,000 | $-26,043,000 |
| Gain Loss On Sale Of PPE | $0 | $271,000 | $-30,000 | $21,000 |
| Net Income From Continuing Operations | $-60,606,000 | $-64,663,000 | $-83,068,000 | $152,000 |
| Income Tax Paid Supplemental Data | - | $0 | $403,000 | $150,000 |
| Common Stock Payments | - | $0 | $-1,019,000 | $-9,000,000 |
| Purchase Of Investment | - | $0 | $-9,595,000 | $-117,508,000 |
| Net Business Purchase And Sale | - | $0 | $-4,456,000 | $-8,577,000 |
| Purchase Of Business | - | $0 | $-4,456,000 | $-8,577,000 |
| Change In Tax Payable | - | $0 | $-255,000 | $123,000 |
| Change In Income Tax Payable | - | $0 | $-255,000 | $123,000 |
| Asset Impairment Charge | - | $0 | $18,887,000 | $10,420,000 |
| Issuance Of Debt | - | - | $0 | $110,000,000 |
| Long Term Debt Issuance | - | - | $0 | $110,000,000 |
| Net Intangibles Purchase And Sale | - | - | - | $0 |
| Purchase Of Intangibles | - | - | - | $0 |
Fetched: 2026-06-13